前往化源商城

129-03-3

129-03-3结构式
129-03-3结构式
  • 常用中文名:塞庚啶
  • 常用英文名:Cyproheptadine
  • CAS号:129-03-3
  • 分子式:C21H22ClN
  • 分子量:323.85900
  • 相关类别: 信号通路 细胞凋亡 细胞凋亡
  • 发布时间:2018-08-04 08:22:48
  • 更新时间:2024-01-02 12:56:11
  • 赛庚啶是一种口服有效的5-HT2A受体拮抗剂,具有抗抑郁和抗腐烂作用。赛庚啶具有抗血小板和血栓保护活性。赛庚啶可用于研究血栓栓塞性疾病[1][2]。

化源商城直购

中文名 塞庚啶
英文名 cyproheptadine
中文别名 二苯环庚啶
英文别名 cyproheptadiene
EINECS 204-928-9
Dronactin
Periactine
Periactinol
MFCD00242817
Eiproheptadine
Cyproheptadine
1-methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine
MK 141
4-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
Periactin
Cypoheptadine
4-dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine
Periactin(R)
描述 赛庚啶是一种口服有效的5-HT2A受体拮抗剂,具有抗抑郁和抗腐烂作用。赛庚啶具有抗血小板和血栓保护活性。赛庚啶可用于研究血栓栓塞性疾病[1][2]。
相关类别
体外研究 赛庚啶(0.01-100 nM;1分钟)在体外剂量依赖性地抑制5-羟色胺增强的ADP诱导的小鼠血小板聚集[2]。赛庚啶(10 nM)能够在体外抑制血小板中15µM血清素增强的ADP诱导的(1µM)酪氨酸磷酸化[2]。赛庚啶在体外抑制人血小板PS暴露(膜联蛋白V)、P-选择素和GPIIb-IIIa(PAC-1结合)激活[2]。
体内研究 赛庚啶(1 mg/kg;静脉注射;每天,持续5天;C57BL/6小鼠)在体内发挥血栓保护作用[2]。动物模型:C57BL/6小鼠(8-10周龄)[2]剂量:1mg/kg给药:腹腔注射;每天一次,连续5天。结果:小鼠阻塞时间和尾部出血时间延长。
参考文献

[1]. Calka O, et, al. Effect of cyproheptadine on serum leptin levels. Adv Ther, 2005. 22(5): p. 424-8.

[2]. Olivia A Lin, et al. The Antidepressant 5-HT2A Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function. PLoS One. 2014; 9(1): e87026.

密度 1.115g/cm3
沸点 440.1ºC at 760mmHg
熔点 298 °C (dec.)(lit.)
分子式 C21H22ClN
分子量 323.85900
闪点 194.5ºC
精确质量 323.14400
PSA 3.24000
LogP 5.43780
外观性状 无色液体,甜的,杏仁气味
蒸汽压 6.03E-08mmHg at 25°C
折射率 1.5339 (20ºC)
计算化学

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:1

4.可旋转化学键数量:0

5.互变异构体数量:无

6.拓扑分子极性表面积3.2

7.重原子数量:22

8.表面电荷:0

9.复杂度:423

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TM7000000
CHEMICAL NAME :
Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-
CAS REGISTRY NUMBER :
129-03-3
BEILSTEIN REFERENCE NO. :
1685976
LAST UPDATED :
199706
DATA ITEMS CITED :
12
MOLECULAR FORMULA :
C21-H21-N
MOLECULAR WEIGHT :
287.43
WISWESSER LINE NOTATION :
L C676 BYJ BU- DT6N DYTJ A1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
295 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,69,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
52 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,69,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
106 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1723,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
43300 ug/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1723,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
107 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,69,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 25,1723,1975
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZIAQ "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973 Volume(issue)/page/year: -,82,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
3500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,69,1972 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
10 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 257,168,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
20 mg/kg
SEX/DURATION :
female 13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 257,168,1982
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
20 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 257,168,1982

包装等级 I; II; III
海关编码 29143900

~99%

129-03-3结构式

129-03-3

文献:Hatano, Manabu; Ito, Orie; Suzuki, Shinji; Ishihara, Kazuaki Journal of Organic Chemistry, 2010 , vol. 75, # 15 p. 5008 - 5016

~%

129-03-3结构式

129-03-3

文献:Archiv der Pharmazie, , vol. 329, # 2 p. 87 - 94

~%

129-03-3结构式

129-03-3

文献:Tetrahedron, , vol. 44, # 19 p. 6197 - 6200

~%

129-03-3结构式

129-03-3

文献:Tetrahedron, , vol. 44, # 19 p. 6197 - 6200

~%

129-03-3结构式

129-03-3

文献:Archiv der Pharmazie, , vol. 329, # 2 p. 87 - 94
海关编码 2933399090
中文概述 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%